{"url_path":"/sec/rckt/8-k/2026-06-12/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1281895/0001140361-26-024997-index.html","accession_number":"0001140361-26-024997","cik":"0001281895","ticker":"RCKT","issuer_name":"ROCKET PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1281895/0001140361-26-024997-index.html","primary_entity_key":"0001281895","primary_entity_name":"ROCKET PHARMACEUTICALS, INC."},"word_count":110,"has_tables":true,"body_markdown":"Item 7.01.\n\nRegulation FD Disclosure.\n\nOn June 12, 2026, the Company issued a press release announcing the closing of the Asset Sale, a copy\nof the which is furnished as Exhibit 99.1 hereto.\n\nThe information under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act\nof 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act or the Exchange Act, except as shall\nbe expressly set forth by specific reference in such filing."}